Cited by 866Liver physiology and pathologyWound Healing and TreatmentsLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 126 of the 128 references it cites were found in a registry or an index.

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

Open access

Iredale, John P.·2007·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

Models of liver fibrosis, which include cell culture models, explanted and biopsied human material, and experimental animal models, have demonstrated that liver fibrosis is a highly dynamic example of solid organ wound healing. Recent work in human and animal models has shown that liver fibrosis is potentially reversible and, in specific circumstances, demonstrates resolution with a restoration of near normal architecture. This Review highlights the manner in which studies of models of liver fibrosis have contributed to the paradigm of dynamic wound healing in this solid organ.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci30542

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Liver fibrosis
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Self-citation
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
Álvarez‐Dolado, M., Pardal, R., García‐Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., Lois, C., Morrison, S. J., & Álvarez-Buylla, A. (2003) · Nature · doi:10.1038/nature02069 · Cited by 1,617

Show all 128 references

Research works printed but not linked: 9

10.1172/JCI200524282 · DOI · Paper page
Otto, 1980, Adv. Exp. Med. Biol., 132, 509
Constandinou, 2005, Methods Mol. Med., 117, 237
Montfort, 1978, Am. J. Pathol., 92, 411
Jeong, 2002, Anticancer Res., 22, 869
Okazaki, 1998, Lab. Invest., 78, 1431
10.1172/JCI200320530 · DOI
10.1053/gast.1996.v110.pm8608892 · DOI · Paper page
10.1074/jbc.275.4.2247 · DOI

Sorted by citations

Items 201–300 of 865

The liver pharmacological and xenobiotic gene response repertoire
Natsoulis, G., Pearson, C. I., Gollub, J., Eynon, B. P., Ferng, J., Nair, R. V., Idury, R., Lee, M. D., Fielden, M. R., Brennan, R., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.9 · Cited by 77
Chalcones as putative hepatoprotective agents: Preclinical evidence and molecular mechanisms
Karimi‐Sales, E., Mohaddes, G., & Alipour, M. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.022 · Cited by 76
FibroGENE: A gene-based model for staging liver fibrosis
Eslam, M., Hashem, A. M., Romero‐Gómez, M., Berg, T., Dore, G. J., Mangia, A., Chan, H. L., Irving, W. L., Sheridan, D. A., Abate, M. L., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.008 · Cited by 75
Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients
Glässner, A., Eisenhardt, M., Kokordelis, P., Krämer, B., Wolter, F., Nischalke, H. D., Boesecke, C., Sauerbruch, T., Rockstroh, J. K., Spengler, U., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.029 · Cited by 75
Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: Potential role in liver fibrosis
Amara, S., López, K., Banan, B., Brown, S.-K., Whalen, M. M., Myles, E. L., Ivy, M. T., Johnson, T. L., Schey, K. L., & Tiriveedhi, V. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.10.021 · Cited by 74
PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis
Yang, Y., Wu, X.-Q., Li, W.-X., Huang, H.-M., Li, H.-D., Pan, X.-Y., Li, X.-F., Huang, C., Meng, X.-M., Zhang, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0383-0 · Cited by 72
Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis
Cai, C. X., Buddha, H., Castelino‐Prabhu, S., Zhang, Z., Britton, R. S., Bacon, B. R., & Neuschwander‐Tetri, B. A. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4470-9 · Cited by 76
Surgical inflammation: a pathophysiological rainbow
Arias, J. I., Aller, M., & Árias, J. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-19 · Cited by 74
Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats
Yang, J., Hou, Y., Ji, G., Song, Z., Liu, Y., Dai, G., Zhang, Y., & Chen, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.11.017 · Cited by 72
Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice
de Meijer, V. E., Sverdlov, D., Popov, Y. V., Le, H. D., Meisel, J. A., Nosé, V., Schuppan, D., & Puder, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011256 · Cited by 73
Role of thrombospondin 1 in liver diseases
Li, Y., Turpin, C., & Wang, S. (2016) · Hepatology Research · doi:10.1111/hepr.12787 · Cited by 74
Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture
Xu, Z., Castellino, F., & Ploplis, V. A. (2009) · Blood · doi:10.1182/blood-2009-09-244962 · Cited by 71
Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro
Wang, H., Huang, X., Shen, P., Li, L., XUE, H.-T., & Ji, G. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1285 · Cited by 71
Matrix metalloproteinase-1 treatment of muscle fibrosis
Kaar, J. L., Li, Y., Blair, H. C., Asche, G., Koepsel, R. R., Huard, J., & Russell, A. J. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.03.010 · Cited by 71
3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model
Farrar, C. T., DePeralta, D. K., Day, H., Rietz, T. A., Wei, L., Lauwers, G. Y., Keil, B. R., Subramaniam, A., Sinskey, A. J., Tanabe, K. K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.029 · Cited by 70
The use of low molecular weight heparin–pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathway
Lee, J., Lee, H., Joung, Y. K., Jung, K. H., Choi, J.-H., Lee, D., Park, K. D., & Hong, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.023 · Cited by 70
Cell Signals Influencing Hepatic Fibrosis
Cong, M., Iwaisako, K., Jiang, C., & Kisseleva, T. (2012) · International Journal of Hepatology · doi:10.1155/2012/158547 · Cited by 74
Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease
Destrempes, F., Gesnik, M., Chayer, B., Cardinal, M. R., Olivié, D., Giard, J., Sebastiani, G., Nguyen, B., Cloutier, G., & Tang, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262291 · Cited by 69
Coagulation and fibrosis in chronic liver disease
Calvaruso, V., Maimone, S., Gatt, A., Tuddenham, E. G. D., Thursz, M. R., Pinzani, M., & Burroughs, A. K. (2008) · Gut · doi:10.1136/gut.2008.150748 · Cited by 67
The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis
Kramann, R., & Schneider, R. K. (2018) · Blood · doi:10.1182/blood-2018-02-834820 · Cited by 62
HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis
Xie, X., Lv, H., Liu, C., Su, X., Yu, Z., Song, S., Bian, H., Tian, M., Qin, C., Qi, J., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02085-3 · Cited by 65
Genetic modifiers of non-alcoholic fatty liver disease progression
Anstee, Q. M., Daly, A. K., & Day, C. P. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.017 · Cited by 67
Reversibility and heritability of liver fibrosis: Implications for research and therapy
Atta, H. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5138 · Cited by 68
Osteopontin – A potential biomarker of advanced liver disease
Brůha, R., Vı́tek, L., & Smid, V. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.01.001 · Cited by 66
Mechanisms Underlying Latent Disease Risk Associated with Early-Life Arsenic Exposure: Current Research Trends and Scientific Gaps
Bailey, K. A., Smith, A. H., Tokar, E. J., Graziano, J. H., Kim, K., Navasumrit, P., Ruchirawat, M., Thiantanawat, A., Suk, W. A., & Fry, R. C. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1409360 · Cited by 66
MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation
Huang, Y., Kuo, H., Yang, Y., & Wang, F. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.29930 · Cited by 65
Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis
Wu, Y., Cao, Y., Xu, K., Zhu, Y., Qiao, Y., Wu, Y., Chen, J., Li, C., Zeng, R., & Ge, G. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03443-y · Cited by 69
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
Weiskirchen, R., Mahli, A., Weiskirchen, S., & Hellerbrand, C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00140 · Cited by 65
Virus-related liver cirrhosis: Molecular basis and therapeutic options
Lin, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i21.6457 · Cited by 68
Experimental obstructive cholestasis: the wound-like inflammatory liver response
Aller, M., Arias, J.-L., García-Domínguez, J., Árias, J., Durán, M., & Árias, J. (2008) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-1-6 · Cited by 63
CM-101: Type I Collagen–targeted MR Imaging Probe for Detection of Liver Fibrosis
Farrar, C. T., Gale, E. M., Kennan, R. P., Ramsay, I. A., Masia, R., Arora, G., Looby, K., Wei, L., Kalpathy–Cramer, J., Bunzel, M. M., et al. (2017) · Radiology · doi:10.1148/radiol.2017170595 · Cited by 65
Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis
Zhang, F., Lu, Y., & Zheng, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.008 · Cited by 65
Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis
Yao, Q., Lin, Y.-Z., Li, X., Shen, X., Wang, J., & Tu, C. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.06.240 · Cited by 64
Smaddening Complexity: The Role of Smad3 in Epithelial-Myofibroblast Transition
Masszi, A., & Kapùs, A. (2010) · Cells Tissues Organs · doi:10.1159/000320180 · Cited by 67
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems
Reichenbach, V., Ros, J., Fernández‐Varo, G., Casals, G., Melgar‐Lesmes, P., Campos, T., Makriyannis, A., Morales‐Ruiz, M., & Jiménez, W. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188078 · Cited by 64
Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
Seo, W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i4.1348 · Cited by 64
Neutrophils promote alveolar epithelial regeneration by enhancing type II pneumocyte proliferation in a model of acid-induced acute lung injury
Paris, A. J., Liu, Y., Mei, J., Dai, N., Guo, L., Spruce, L. A., Hudock, K. M., Brenner, J. S., Zacharias, W. J., Mei, H. D., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00327.2016 · Cited by 65
The Origin and Fate of Liver Myofibroblasts
Kim, H. Y., Sakane, S., Eguileor, A., Carvalho Gontijo Weber, R., Lee, W., Liu, X., Lam, K., Ishizuka, K., Rosenthal, S. B., Diggle, K., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.008 · Cited by 63
Innate immunity and alcoholic liver fibrosis
Jeong, W., & Gao, B. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05274.x · Cited by 63
Versican: a novel modulator of hepatic fibrosis
Bukong, T. N., Maurice, S. B., Chahal, B., Schaeffer, D. F., & Winwood, P. J. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.152 · Cited by 59
Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review
Hoan, N. X., Tong, H. V., Song, L. H., Meyer, C. G., & Velavan, T. P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i4.445 · Cited by 62
Anti-fibrotic treatments for chronic liver diseases: The present and the future
Odagiri, N., Matsubara, T., Sato-Matsubara, M., Fujii, H., Enomoto, M., & Kawada, N. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0187 · Cited by 64
Relaxin decreases the severity of established hepatic fibrosis in mice
Bennett, R. G., Heimann, D. G., Singh, S. K., Simpson, R. L., & Tuma, D. J. (2013) · Liver International · doi:10.1111/liv.12247 · Cited by 62
Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis
Gao, B., Radaeva, S., & Jeong, W. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.173 · Cited by 66
Keratin Mutation Predisposes to Mouse Liver Fibrosis and Unmasks Differential Effects of the Carbon Tetrachloride and Thioacetamide Models
Strnad, P., Tao, G., Zhou, Q., Harada, M., Toivola, D. M., Brunt, E. M., & Omary, M. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.035 · Cited by 61
T cells and their cytokines in persistent stimulation of the immune system
Kared, H., Camous, X., & Larbi, A. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.05.003 · Cited by 60
Anti-liver fibrosis activity of curcumin/chitosan-coated green silver nanoparticles
Elzoheiry, A., Ayad, E., Omar, N., Elbakry, K., & Hyder, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-23276-9 · Cited by 60
Quantification of liver fibrosis via second harmonic imaging of the Glisson's capsule from liver surface
Xu, S., Kang, C. H., Gou, X., Peng, Q., Yan, J., Zhuo, S., Cheng, C. L., He, Y., Kang, Y., Xia, W., et al. (2015) · Journal of Biophotonics · doi:10.1002/jbio.201500001 · Cited by 60
Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs
Peng, J., Li, X., Feng, Q., Chen, L., Xu, L., & Hu, Y. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213480741 · Cited by 60
MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication
Zhao, F., Wáng, Y. X. J., Yuan, J., Deng, M., Wong, H., Chu, E. S., Go, M. Y. Y., Teng, G., Ahuja, A. T., & Yu, J. Q. (2012) · European Radiology · doi:10.1007/s00330-012-2419-0 · Cited by 60
Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury
Yang, Y., Bai, T., Yao, Y., Zhang, D., Wu, Y., Lian, L., & Nan, J. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.09.014 · Cited by 60
Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04627-0 · Cited by 61
A Multiscale Agent-Based in silico Model of Liver Fibrosis Progression
Dutta‐Moscato, J., Solovyev, A., Mi, Q., Nishikawa, T., Soto–Gutiérrez, A., Fox, I. J., & Yoram Vodovotz, B. (2014) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2014.00018 · Cited by 59
Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis
Mencin, A. M., Seki, E., Osawa, Y., Kodama, Y., Minicis, S. D., Knowles, M. R., & Brenner, D. A. (2007) · Hepatology · doi:10.1002/hep.21832 · Cited by 59
Accelerated and Progressive and Lethal Liver Fibrosis in Mice That Lack Interleukin (IL)-10, IL-12p40, and IL-13Rα2
Mentink‐Kane, M. M., Cheever, A. W., Wilson, M. S., Madala, S. K., Beers, L. M., Ramalingam, T. R., & Wynn, T. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.008 · Cited by 60
Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model
Zhu, B., Wei, L., Rotile, N. J., Day, H., Rietz, T. A., Farrar, C. T., Lauwers, G. Y., Tanabe, K. K., Rosen, B. R., Fuchs, B. C., et al. (2016) · Hepatology · doi:10.1002/hep.28930 · Cited by 59
A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis
Shi, M.-J., Yan, X., Dong, B.-S., Yang, W.-N., Su, S.-B., & Zhang, H. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112689 · Cited by 58
Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-β1 treatment
Zanotti, S., Gibertini, S., & Mora, M. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0889-4 · Cited by 59
Glycyrrhizin regulates CD4+T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway
Tu, C., Li, J., Wang, F.-P., Li, L., Wang, J., & Jiang, W. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.08.013 · Cited by 59
In vivo X-Ray Computed Tomographic Imaging of Soft Tissue with Native, Intravenous, or Oral Contrast
Wathen, C. A., Foje, N., Avermaete, T. V., Miramontes, B., Chapaman, S. E., Sasser, T. A., Kannan, R., Gerstler, S., & Leevy, W. M. (2013) · Sensors · doi:10.3390/s130606957 · Cited by 58
Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis
Zhao, G., Hatting, M., Nevzorova, Y. A., Peng, J., Hu, W., Boekschoten, M. V., Roskams, T., Müller, M. M., Gaßler, N., Liedtke, C., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-305507 · Cited by 58
Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview
Wen, W. X., Lee, S. Y., Siang, R., & Koh, R. Y. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0547-2 · Cited by 58
Hepatitis C and Innate Immunity: Recent Advances
Szabó, G., & Dolganiuc, A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.03.003 · Cited by 56
Fibrogenic signalling in hepatic stellate cells
Mann, D. A., & Marra, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.005 · Cited by 57
the C-Rel Subunit of Nuclear Factor-κB Regulates Murine Liver Inflammation, Wound-Healing, and Hepatocyte Proliferation
Gieling, R. G., Elsharkawy, A. M., Caamaño, J., Cowie, D. E., Wright, M. C., Ebrahimkhani, M. R., Burt, A. D., Mann, J., Raychaudhuri, P., Liou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23385 · Cited by 58
The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure
Song, W., & Wang, X. (2015) · Biophysical Reviews · doi:10.1007/s12551-014-0158-y · Cited by 56
Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways
Hernández‐Aquino, E., Quezada‐Ramírez, M. A., Silva-Olivares, A., Casas‐Grajales, S., Ramos‐Tovar, E., Flores‐Beltrán, R. E., Segovia, J., Shibayama, M., & Muriel, P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172730 · Cited by 57
Mesodermal Mesenchymal Cells Give Rise to Myofibroblasts, but Not Epithelial Cells, in Mouse Liver Injury
Lua, I., James, D., Wang, J., Wang, K. S., & Asahina, K. (2014) · Hepatology · doi:10.1002/hep.27035 · Cited by 55
Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism
Beier, J. I., & Arteel, G. E. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011255 · Cited by 56
PAI-1 plays a protective role in CCl 4 -induced hepatic fibrosis in mice: role of hepatocyte division
von Montfort, C., Beier, J. I., Kaiser, J. P., Guo, L., Joshi‐Barve, S., Pritchard, M. T., States, J. C., & Arteel, G. E. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00107.2009 · Cited by 56
Mutant MMP-9 and HGF Gene Transfer Enhance Resolution of CCl4-Induced Liver Fibrosis in Rats: Role of ASH1 and EZH2 Methyltransferases Repression
Atta, H. M., Elrehany, M. A., Hammam, O. A., Abdelghany, H. M., Ramzy, M. M., Roderfeld, M., Roeb, E., Al-Hendy, A., Abdelraheim, S. R., Allam, H. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112384 · Cited by 57
Induction of Heme Oxygenase 1 Prevents Progression of Liver Fibrosis in Mdr2 Knockout Mice
Barikbin, R., Neureiter, D., Wirth, J., Erhardt, A., Schwinge, D., Kluwe, J., Schramm, C., Tiegs, G., & Sass, G. (2011) · Hepatology · doi:10.1002/hep.24711 · Cited by 56
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
Athwal, V. S., Pritchett, J. P., Llewellyn, J., Martin, K., Camacho, E. M., Raza, S., Phythian‐Adams, A., Birchall, L., Mullan, A. F., Su, K., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707860 · Cited by 53
Hepatic Fibrosis in Dogs
Eulenberg, V., & Lidbury, J. A. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14891 · Cited by 60
Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis
Zhang, J., Muise, E. S., Han, S., Kutchukian, P. S., Costet, P., Zhu, Y., Kan, Y., Zhou, H., Shah, V., Huang, Y., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100056 · Cited by 55
S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression
Liu, Y., Kong, X., You, Y., Xiang, L., Zhang, Y., Wu, R., Zhou, L., & Duan, L. (2022) · Cells · doi:10.3390/cells11223579 · Cited by 54
A Transgenic Model for Conditional Induction and Rescue of Portal Hypertension Reveals a Role of VEGF-Mediated Regulation of Sinusoidal Fenestrations
May, D., Djonov, V., Zamir, G. A., Bala, M., Safadi, R., Sklair‐Levy, M., & Keshet, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021478 · Cited by 54
Modulation of Liver Inflammation and Fibrosis by Interleukin-37
Mountford, S., Effenberger, M., Noll‐Puchta, H., Griessmair, L., Ringleb, A., Haas, S., Denk, G., Reiter, F. P., Mayr, D. C., Dinarello, C. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.603649 · Cited by 57
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis
Giannone, F. A., Baldassarre, M., Domenicali, M., Zaccherini, G., Trevisani, F., Bernardi, M., & Caraceni, P. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.191 · Cited by 54
Vascular biology and pathobiology of the liver: Report of a single-topic symposium
Iwakiri, Y., Grisham, M. B., & Shah, V. H. (2008) · Hepatology · doi:10.1002/hep.22203 · Cited by 53
Modulation of thioacetamide-induced hepatic inflammations, angiogenesis and fibrosis by andrographolide in mice
Lee, T.-Y., Chang, H., Wen, C.-K., Huang, T., & Chang, Y. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.056 · Cited by 53
Hepatic wound repair
Parola, M., & Pinzani, M. (2009) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-2-4 · Cited by 53
Strategies to prevent and reverse liver fibrosis in humans and laboratory animals
Chen, R.-J., Wu, H.-H., & Wang, Y. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1525-6 · Cited by 53
Adverse outcome pathway development from protein alkylation to liver fibrosis
Horvat, T., Landesmann, B., Lostia, A., Vinken, M., Munn, S., & Whelan, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1814-8 · Cited by 56
Artificial urinary biomarker probes for diagnosis
Xu, C., & Pu, K. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00153-w · Cited by 58
Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver
Zimmermann, H. W., Bruns, T., Weston, C. J., Curbishley, S. M., Liaskou, E., Li, K., Resheq, Y. J., Badenhorst, P. W., & Adams, D. (2015) · Hepatology · doi:10.1002/hep.28285 · Cited by 50
Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad signaling pathways and up-regulation of MMP-2/TIMP-1 ratio
Xie, H., Su, D., Zhang, J., Ji, D., Mao, J., Hao, M., Wang, Q., Yu, M., Mao, C., & Lu, T. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.01.045 · Cited by 52
Gut Microbiome and Organ Fibrosis
Costa, C. F. F. A., Sampaio‐Maia, B., Araújo, R., Nascimento, D. S., Ferreira‐Gomes, J., Pestana, M., Azevedo, M. J., & Alencastre, I. S. (2022) · Nutrients · doi:10.3390/nu14020352 · Cited by 53
Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management
Islam, R., Kundu, S., Jha, S. B., Rivera, A. P., Monar, G. V. F., Islam, H., Puttagunta, S. M., & Sange, I. (2022) · Cureus · doi:10.7759/cureus.23785 · Cited by 51
Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation
Pan, Q., Gao, M., Kim, D.-M., Ai, W., Yang, W., Jiang, W. G., Brashear, W. A., Dai, Y., Li, S., Sun, Y., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.08.013 · Cited by 54
Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice
Ye, L., Yu, H., Li, C., Hirsch, M. L., Zhang, L., Samulski, R. J., Li, W., & Liu, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130052 · Cited by 54
Hepatoprotective effects of misoprostol and silymarin on carbon tetrachloride‐induced hepatic damage in rats
Abdel‐Salam, O. M. E., Sleem, A. A., Omara, E. A. A., & Hassan, N. S. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00654.x · Cited by 51
Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice
Chow, L. N. Y., Schreiner, P., Ng, B. Y. Y., Lo, B. C., Hughes, M. R., Scott, R. W., Gusti, V., Lecour, S., Simonson, E., Manisali, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151765 · Cited by 51
Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats
Li, J., Liu, P., Zhang, R., Cao, L., Qian, H., Liao, J., Xu, W. R., Wu, M., & Yin, Z.-F. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.030 · Cited by 50
Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts
Artaza, J. N., Singh, R., Ferrini, M. G., Braga, M., Tsao, J., & González-Cadavid, N. F. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0408 · Cited by 49
Gene expression profiles reveal molecular mechanisms involved in the progression and resolution of bleomycin-induced lung fibrosis
Cabrera, S., Selman, M., Lonzano-Bolaños, A., Konishi, K., Richards, T. J., Kaminski, N., & Pardo, A. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00320.2012 · Cited by 50
A deleterious role for Th9/IL-9 in hepatic fibrogenesis
Qin, S., Lu, D., Guo, X., Luo, W., Hu, B.-L., Huang, X., Chen, M., Wang, J.-X., Ma, S.-J., Yang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep18694 · Cited by 50
Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
Liu, Q., Wang, S., Fu, J., Chen, Y., Xu, J., Wei, W., Song, H., Zhao, X., & Wang, H. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1812 · Cited by 49
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
Fausther, M., Lavoie, É. G., & Dranoff, J. A. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0020-0 · Cited by 49
Evaluation of fibrosis in precision-cut tissue slices
Westra, I. M., Pham, B. T., Groothuis, G. M. M., & Olinga, P. (2012) · Xenobiotica · doi:10.3109/00498254.2012.723151 · Cited by 50

Authors: Iredale, J. P.
Affiliations: Centre for Inflammation Research (GB)
Corresponding author: Iredale, John P.
ORCID: Iredale, John P.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2007-03-01
Volume: 117
Issue: 3
Pages: 539-548
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci30542
PMC: PMC1804370
OpenAlex: W2120335459
Cited by: 866
References: 128
Citations by year: 2026: 19 · 2025: 40 · 2024: 45 · 2023: 39 · 2022: 32 · 2021: 39 · 2020: 34 · 2019: 36 · 2018: 39 · 2017: 36 · 2016: 51 · 2015: 63 · 2014: 61 · 2013: 57 · 2012: 55
FWCI: 7.58
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders: Wellcome Trust
Children's Liver Disease Foundation
Medical Research Council
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Surgery › Wound Healing and Treatments
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: liver fibrosis, wound healing, inflammation, tissue repair, animal models, cell culture model, liver regeneration
MeSH terms: Animals, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Humans, Inflammation, Liver Cirrhosis, Liver Cirrhosis, Experimental, Liver Regeneration, Models, Biological, Wound Healing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks